Laddar...
The Identification of Immunological Biomarkers in Kidney Cancers
The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...
Sparad:
| I publikationen: | Front Oncol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/ https://ncbi.nlm.nih.gov/pubmed/30450335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|